Skip to content
ContentLora

    Tip: press / anywhere to search.

    Analysis

    Harm reduction: what the evidence says on syringe programs and OPCs

    NIDA says evidence from more than 20 years of overdose prevention centers abroad shows no one has died of an overdose inside one, but it is unclear whether they lower overdose deaths overall.[1] A July 2025 executive order told SAMHSA not to fund harm reduction efforts that, in the order's words, only facilitate drug use, and Spectrum News reports that sterile syringes and fentanyl test strips are no longer on SAMHSA's list of items federal funds can pay for.[2][3] A 2026 modeling study projected that ending federal syringe-program funding could add 1,100 to 39,600 deaths over five years.[4]

    Editor reviewedStrict sourcingUpdated Analysis15 claims · 100% primaryDrugs, alcohol and addiction, Tech policy
    Show:

    In an overdose emergency, call 911 and give naloxone if available.[5][6] For confidential treatment referrals, call the SAMHSA National Helpline at 1-800-662-HELP (4357).[7]

    This page sets out evidence and positions on a contested policy question. It is not medical or legal advice, and it attributes political positions to those who hold them.

    This page looks at two harm reduction services that are at the center of the US debate: syringe services programs and overdose prevention centers. Since July 2025 federal policy has moved away from funding them.[2] This page sets out what the research says and how each side reads it.

    Overdose prevention centers

    NIDA describes overdose prevention centers (also called supervised consumption rooms or safe injection sites) as places where people use drugs they obtained elsewhere in a controlled setting, with staff trained to detect and respond to overdoses and connect people to health and support services.[8]

    According to NIDA, evidence from more than 20 years of overdose prevention centers in other countries indicates that no one has died of an overdose while at one, but it is unclear whether they reduce overdose death rates overall.[1] Research summarized by NIDA associates them with less public drug use, lower demand on local emergency services, no increase in crime, and more access to addiction treatment.[9] NIDA funds research on US centers but does not fund their operation.[10]

    Syringe services programs

    Syringe services programs provide sterile injection equipment and other harm reduction services, which can include wound care, naloxone, infectious disease care and links to opioid use disorder medication.[11] Sharing needles and syringes among people who inject drugs is one way hepatitis C spreads, according to WHO.[12] Xylazine, often added to fentanyl, is linked to skin wounds; see xylazine explained.[13][14]

    A June 2026 modeling study in JAMA Network Open, covering about 3.7 million hypothetical people who inject drugs, projected that ending federal funding for syringe services programs would increase deaths in that group by 1,100 to 39,600 over five years, including 500 to 15,600 more opioid overdose deaths.[4]

    The 2025 federal shift

    A July 2025 executive order directed HHS to ensure that SAMHSA’s discretionary grants fund evidence-based programs and do not fund programs that fail to achieve adequate outcomes, naming so-called harm reduction or safe consumption efforts that, in the order’s words, only facilitate illegal drug use and its attendant harm.[2] The same order told the Attorney General to prioritize funding for drug courts and mental health courts, and directed support for assisted outpatient treatment tied to civil commitment.[15]

    Spectrum News reports that SAMHSA has redefined which items can be paid for with federal funding, so that fentanyl test strips, sterile syringes and pipes are no longer on the list. It says the change helps SAMHSA comply with the order.[3]

    How each side reads the evidence

    Supporters of harm reduction emphasize the outcomes that are best documented: no deaths inside supervised sites over two decades, links to treatment, and no rise in crime.[1][9] They also point to the 2026 model, which projected 1,100 to 39,600 additional deaths over five years.[4]

    The administration’s position, set out in the executive order, is that SAMHSA grants should fund evidence-based programs and not programs that fail to achieve adequate outcomes, including harm reduction efforts that, in the order’s words, only facilitate illegal drug use; it also prioritizes drug courts and treatment linked to civil commitment.[2][15]

    The strongest evidence and the hardest questions do not fully overlap. NIDA itself says it is unclear whether overdose prevention centers reduce overall overdose death rates, and the model’s projected range spans more than thirtyfold.[1][4]

    Naloxone distribution and fentanyl test strips are covered in other explainers in this series. This page does not cover state or city decisions on opening or closing overdose prevention centers.

    Competing views

    Harm reduction keeps people alive

    Supporters point to NIDA's finding of no overdose deaths inside supervised sites, links to treatment, and a model projecting additional deaths if syringe programs lose federal funding.[1][9][11][4]

    Fund treatment and recovery instead

    The 2025 executive order directs federal grants toward programs it judges to achieve adequate outcomes, drug courts and civil-commitment-linked treatment, and away from harm reduction efforts it says only facilitate drug use.[2][15]

    The evidence has real gaps

    NIDA says it is unclear whether overdose prevention centers lower overall death rates, and the model's projections span a wide range across scenarios.[1][4]

    Next in the crash course

    More in Drugs & addiction

    Questions readers ask

    What is an overdose prevention center?

    NIDA describes overdose prevention centers, also called supervised consumption rooms or safe injection sites, as places where people use drugs obtained elsewhere in a controlled setting, with staff trained to respond to overdoses and connect people to health services and treatment.[8]

    Do overdose prevention centers reduce deaths?

    NIDA says evidence from more than 20 years abroad shows no one has died of an overdose at one, but it is unclear whether they reduce overdose death rates overall. Research also links them to less public drug use and no increase in crime.[1][9]

    What do syringe services programs do?

    They provide sterile injection equipment and can offer wound care, naloxone, infectious disease care and links to opioid use disorder medication. Sharing needles and syringes spreads infections such as hepatitis C.[11][12]

    What did the 2025 executive order change?

    It directed HHS to ensure SAMHSA grants do not fund programs that fail to achieve adequate outcomes, naming harm reduction and safe consumption efforts, and told the Attorney General to prioritize drug courts and mental health courts.[2][15]

    What could ending federal syringe-program funding do?

    A June 2026 JAMA Network Open model projected 1,100 to 39,600 additional deaths among people who inject drugs over five years, including 500 to 15,600 more opioid overdose deaths, across the scenarios it tested.[4]

    Sources

    · 15 claims from 7 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      NIDA says evidence from more than 20 years of overdose prevention centers abroad indicates no one has died of an overdose at one, but it is unclear whether they reduce overdose death rates overall. confirmedas of 2026-11-07

    2. [2]

      A July 2025 executive order directed HHS to ensure SAMHSA discretionary grants do not fund programs that fail to achieve adequate outcomes, naming so-called harm reduction or safe consumption efforts that, in the order's words, only facilitate illegal drug use. confirmedas of 2026-11-07

    3. [3]

      Spectrum News reports that SAMHSA has redefined which items can be reimbursed with federal funding, so that fentanyl test strips, sterile syringes and pipes are no longer on the list, a change it says helps SAMHSA comply with the July 2025 executive order. reportedas of 2026-11-14

    4. [4]

      A June 2026 JAMA Network Open modeling study of about 3.7 million hypothetical people who inject drugs projected that ending federal funding for syringe services programs would increase deaths in that group by 1,100 to 39,600 over 5 years, including 500 to 15,600 more opioid overdose deaths. confirmedas of 2026-11-07

    5. [5]

      In the US, poison control can be reached at 1-800-222-1222, and people in immediate danger should call 911. confirmedas of 2026-11-07

      • Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
      • Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
    6. [6]

      Naloxone does not reverse xylazine, but CDC and NIDA say it should still be given in a suspected overdose because opioids such as fentanyl are often present, and CDC says 911 should be called because xylazine's effects can continue. confirmedas of 2026-11-07

      • What You Should Know About Xylazine · Centers for Disease Control and Prevention · Primary source · Should naloxone be given in the case of an overdose involving xylazine? (retrieved 2026-11-07)
      • What You Should Know About Xylazine · Centers for Disease Control and Prevention · Primary source · Should naloxone be given in the case of an overdose involving xylazine? (retrieved 2026-11-07)
      • Xylazine · National Institute on Drug Abuse · Primary source · Highlights (retrieved 2026-11-07)
    7. [7]

      The SAMHSA National Helpline, 1-800-662-HELP (4357), and FindTreatment.gov give US referrals to substance use and mental health treatment programs. confirmedas of 2026-11-07

      • Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
    8. [8]

      NIDA describes overdose prevention centers (also called supervised consumption rooms or safe injection sites) as places where people use drugs obtained elsewhere in a controlled setting, with staff trained to respond to overdoses and connect people to services. confirmedas of 2026-11-07

    9. [9]

      NIDA says research associates overdose prevention centers with less public drug use, lower demand on local emergency services, no increase in crime, and more access to addiction treatment. confirmedas of 2026-11-07

    10. [10]

      NIDA funds research on overdose prevention centers in the United States but does not fund their operation. confirmedas of 2026-11-07

    11. [11]

      Syringe services programs provide sterile injection equipment and other harm reduction services, which can include wound care, naloxone, infectious disease care and links to opioid use disorder medication. confirmedas of 2026-11-07

    12. [12]

      WHO says hepatitis C spreads through contact with infected blood, including the sharing of needles and syringes among people who inject drugs. confirmedas of 2026-11-07

    13. [13]

      People often take xylazine without knowing it, because it is added to other drugs, most often fentanyl. confirmedas of 2026-11-07

      • Xylazine · National Institute on Drug Abuse · Primary source · Highlights (retrieved 2026-11-07)
      • What You Should Know About Xylazine · Centers for Disease Control and Prevention · Primary source · How are people exposed to xylazine? (retrieved 2026-11-07)
    14. [14]

      Repeated xylazine use is associated with skin wounds such as ulcers and abscesses that can become infected and, in rare severe cases, lead to amputation; clinicians report wounds even in people who do not inject. confirmedas of 2026-11-07

      • Xylazine · National Institute on Drug Abuse · Primary source · Highlights (retrieved 2026-11-07)
      • Xylazine · National Institute on Drug Abuse · Primary source · How does xylazine affect the mind and body? (retrieved 2026-11-07)
      • Xylazine · National Institute on Drug Abuse · Primary source · How does xylazine affect the mind and body? (retrieved 2026-11-07)
    15. [15]

      The same order told the Attorney General to prioritize funding for drug courts and mental health courts and directed support for assisted outpatient treatment linked to civil commitment. confirmedas of 2026-11-07

    Revision history (3)
    1. Attributed the summary's line on federal funding cuts to news reports.
    2. Narrowed the federal funding sentences to what Spectrum News reports about SAMHSA's list of reimbursable items.
    3. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.

    Cite this page

    "Harm reduction: what the evidence says on syringe programs and OPCs." ContentLora, updated Nov 14, 2026. https://contentlora.com/analysis/harm-reduction-evidence-debate

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.